Elsevier

Metabolism

Volume 46, Issue 1, January 1997, Pages 97-106
Metabolism

Dissociated insulinotropic sensitivity to glucose and carbachol in high-fat diet—induced insulin resistance in C57BL/6J mice

https://doi.org/10.1016/S0026-0495(97)90175-XGet rights and content

Abstract

To study islet function following reduced insulin sensitivity, we examined mice of the C57BL/6J strain, the genotype of which carries an increased propensity to develop insulin resistance when metabolically challenged. The mice received either a high-fat diet (58% fat on an energy basis) or a control diet (11% fat) for 12 weeks. The body weight of mice on the high-fat diet increased significantly more than that of mice on the control diet (25.8 ± 0.4 v 21.3 ± 0.2 g, P < .001). Already after 1 week on the high-fat diet, a significant hyperglycemia accompanied by hyperinsulinemia had evolved, indicative of insulin resistance. After 12 weeks, plasma glucose levels for high-fat diet—treated mice were 7.5 ± 0.1 mmol/L, versus 6.5 ± 0.1 mmol/L in controls (P < .001); corresponding values for plasma insulin were 248 ± 17 and 104 ± 7 pmol/L, respectively (P < .001). Mice given a high-fat diet also had elevated levels of total cholesterol, triglycerides, and free fatty acids (FFAs) compared with controls. After 4, 8, and 12 weeks, glucose (2.8, 8.3, or 16.7 mmol/kg) or the cholinergic agonist carbachol (0.16 or 0.53 μmol/kg) was injected intraperitoneally. The insulinotropic response to glucose was not different between the two groups after 4 or 8 weeks, whereas after 12 weeks, glucose-induced insulin secretion was markedly impaired in high-fat diet-treated mice (P < .001). In contrast, after 8 and 12 weeks on a high-fat diet, carbachol-stimulated insulin secretion was potentiated (P < .01), whereas carbachol-stimulated glucagon secretion was not significantly altered. Furthermore, after 12 weeks on the high-fat diet, insulin secretion from isolated islets was impaired at glucose levels of 8.3, 11.1, and 16.7 mmol/L (P ≤ .05). Moreover, islet morphology as examined by immunocytochemistry using insulin antibodies and islet innervation, as revealed by immunostaining of tyrosine hydroxylase (TH), neuropeptide Y (NPY), galanin, vasoactive intestinal polypeptide (VIP), and substance P (SP) were unaffected by the high-fat diet for 12 weeks. However, quantitative in situ hybridization showed a 3.5-fold upregulation of insulin gene expression in response to the high-fat diet (P < .001) despite unaltered B-cell mass and pancreatic insulin content. We conclude that as little as 1 week of treatment with a high-fat diet induces insulin resistance in C57BL/6J mice. This is accompanied later by hyperlipemia, potentiated carbachol-stimulated insulin secretion, and increased insulin gene expression but impaired glucose-stimulated insulin secretion. We suggest that after several weeks' duration, insulin resistance is accompanied by enhanced islet sensitivity to cholinergic activation and exaggerated insulin gene expression, whereas the failing islet sensitivity to glucose represents decompensation.

References (37)

  • B Ahrén et al.

    Modulation of basal insulin secretion in the obese, hyperglycemic mouse

    Metabolism

    (1982)
  • ML Bruss et al.

    Enzymatic microdetermination of glycogen

    Anal Biochem

    (1978)
  • A Antonis

    Semiautomated method for the colorimetric determination of plasma free fatty acids

    J Lipid Res

    (1965)
  • JC Beard et al.

    Dexamethasone-induced insulin resistance enhances B cell responsiveness to glucose level in normal men

    Am J Physiol

    (1984)
  • SE Kahn et al.

    Increased B-cell secretory capacity as mechanism for islet adaptation to nicotinic acid—induced insulin resistance

    Diabetes

    (1989)
  • RN Bergman et al.

    Physiologic evaluation of factors controlling glucose tolerance in man

  • D Porte

    B cells in type 2 diabetes mellitus

    Diabetes

    (1991)
  • B Balkan et al.

    Muscarinic stimulation maintains in vivo insulin secretion in response to glucose after prolonged hyperglycaemia

    Am J Physiol

    (1995)
  • B Ahrén et al.

    Blockade of muscarinic transmission increases the frequency of diabetes after low-dose alloxan challenge in the mouse

    Diabetologia

    (1996)
  • S Fukudo et al.

    Muscarinic stimulation and antagonism and glucoregulation in nondiabetic and obese hyperglycemic mice

    Diabetes

    (1989)
  • DL Coleman

    Obese and diabetes: Two mutant genes causing diabetes-obesity syndromes in mice

    Diabetologia

    (1978)
  • DL Coleman et al.

    The influence of genetic background on the expression of the obese (ob) gene in the mouse

    Diabetologia

    (1973)
  • RS Surwit et al.

    Diet-induced type II diabetes in C57BL/6J mice

    Diabetes

    (1988)
  • RS Surwit et al.

    Control of expression of insulin resistance and hyperglycemia by different genetic factors in diabetic C57BL/6J mice

    Diabetes

    (1991)
  • SK Lee et al.

    Defective glucose-stimulated insulin release from perifused islets of C57BL/6J mice

    Pancreas

    (1995)
  • PE Lacy et al.

    Method for the isolation of intact islets of Langerhans from the rat pancreas

    Diabetes

    (1967)
  • V Herbert et al.

    Coated charcoal immunoassay of insulin

    J Clin Endocrinol Metab

    (1965)
  • B Ahrén et al.

    Glucagon immunoreactivity in plasma from normal and dystrophic mice

    Diabetologia

    (1982)
  • Cited by (117)

    • Lisofylline mitigates cardiac inflammation in a mouse model of obesity through improving insulin secretion and activating cardiac AMPK signaling pathway

      2021, Cytokine
      Citation Excerpt :

      We used the HFD obese mouse model introduced by Surwit et al. in 1988 [36]. This model is accompanied by insulin resistance with insufficient islet compensation, and previously used to study the pathophysiology of impaired glucose tolerance and early T2D [37,38]. In agreement with previous studies, we also observed LSF beneficial effects on the metabolic phenotype of this mouse model [26,39,40].

    • Muscarinic Agonist Ameliorates Insulin Secretion in Wfs1-Deficient Mice

      2019, Canadian Journal of Diabetes
      Citation Excerpt :

      IP3 binds to IP3 receptors on the surface of the ER, mobilizing intracellular Ca2+ stores, which leads to an increase in cytoplasmic Ca2+ levels, thus potentiating glucose-stimulated insulin secretion (20–22). Previous reports have shown that the muscarinic agonist carbachol can restore insulin secretion in mice fed a high-fat diet (23) and in spontaneously diabetic Goto-Kakizaki rats (24). The aim of the present study was to investigate insulin-release dynamics in Wfs1-deficient mice and to determine whether stimulating muscarinic receptors diminishes deficiency in insulin secretion caused by the Wfs1 defect.

    View all citing articles on Scopus

    Supported by the Swedish Medical Research Council (14X-6834 and 12X-4499), Novo Nordic, the Albert Påhlsson, Crafoord, Ernhold Lundström, and Ester Ohlssons Foundations, the Diabetes Association of Malmö with surroundings, the Swedish Diabetes Association, Malmö University Hospital, and the Faculty of Medicine, Lund University.

    View full text